Analyze Diet
Journal of the American Veterinary Medical Association2007; 230(12); 1822-1826; doi: 10.2460/javma.230.12.1822

Salinomycin toxicosis in horses.

Abstract: A 4-month-old American Paint filly was evaluated because of sudden onset of ataxia that progressed to recumbency. Five additional horses from the same and neighboring premises developed signs of poor performance, generalized weakness, ataxia, and recumbency; 2 of those horses were also evaluated. A new batch of a commercial feed supplement had been introduced to the horses' diet on each farm within the preceding 3 days. Results: Other than recumbency, findings of physical and neurologic examinations of the foal were unremarkable. The other 2 horses had generalized weakness and mild ataxia, and 1 horse also had persistent tachycardia. The foal had mild leukocytosis with neutrophilia, hyperglycemia, and mildly high serum creatine kinase activity. Results of cervical radiography, CSF analysis, and assessments of heavy metals and selenium concentrations in blood and vitamin E concentration in serum were within reference limits. Feed analysis revealed high concentrations of the ionophore antimicrobial salinomycin. Results: The 5 affected horses survived, but the foal was euthanized. At necropsy, a major histopathologic finding was severe vacuolation within neurons of the dorsal root ganglia, which was compatible with ionophore toxicosis. The surviving horses developed muscle atrophy, persistent weakness, and ataxia. Conclusions: In horses, ionophore toxicosis should be considered as a differential diagnosis for acute weakness, ataxia, recumbency, or sudden death. Furthermore, ionophore toxicosis should be considered as a cause of poor performance, weakness, muscle wasting, and cardiac arrhythmias in horses. Surviving horses may have impaired athletic performance.
Publication Date: 2007-06-19 PubMed ID: 17571983DOI: 10.2460/javma.230.12.1822Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates an incident of salinomycin poisoning in horses, where symptoms such as weakness, coordination loss and recumbency occurred due to the ingestion of a commercial feed supplement containing a high concentration of the ionophore antimicrobial, salinomycin. The findings underscore the need to consider ionophore toxicosis in cases of sudden weakness, ataxia, or recumbency in horses.

Background and Case Presentation

  • The article details the case of a 4-month-old American Paint filly who was examined due to a sudden onset of ataxia (loss of coordination) which progressed to the horse being unable to stand up, a state known as recumbency. Five other horses from the same and neighboring premises also developed similar signs.
  • These symptoms had begun to appear just three days after a new batch of a commercial feed supplement was introduced to the horses’ diets.
  • Among the other horses, two were evaluated in detail. One of them had generalized weakness and mild ataxia, while the other additionally displayed persistently elevated heart rate (tachycardia).

Investigation and Findings

  • In addition to recumbency, the filly horse did not show any significant physical or neurological deviations. However, blood tests revealed mild leukocytosis (increased white blood cells), hyperglycemia (elevated blood sugar), and slightly elevated serum creatine kinase activity, an indicator of muscle damage.
  • All assessed parameters including cervical radiography, cerebrospinal fluid (CSF) analysis, concentrations of heavy metals and selenium in the blood, and vitamin E concentration in the serum were within normal ranges.
  • However, crucially, a feed analysis revealed high concentrations of salinomycin, an ionophore antimicrobial.

Outcomes and Conclusion

  • Although five affected horses survived, the 4-month-old filly was euthanized due to severity of condition. Postmortem investigations showed severe vacuolation (formation of vacuoles or cavities) within the neurons of the dorsal root ganglia, a finding compatible with ionophore toxicosis.
  • The surviving horses developed muscle atrophy, persistent weakness, and ataxia, implying that exposure to ionophores can cause long-term health issues in horses.
  • The findings highlight that ionophore toxicosis could be a potential cause behind sudden weakness, ataxia, recumbency, poor performance, muscle wasting, and cardiac arrhythmias in horses and therefore, it should be considered as a differential diagnosis.
  • The authors conclude with a warning that horses who survive this toxicosis might have their athletic performance permanently impaired.

Cite This Article

APA
Aleman M, Magdesian KG, Peterson TS, Galey FD. (2007). Salinomycin toxicosis in horses. J Am Vet Med Assoc, 230(12), 1822-1826. https://doi.org/10.2460/javma.230.12.1822

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 230
Issue: 12
Pages: 1822-1826

Researcher Affiliations

Aleman, Monica
  • Department of Medicine, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Magdesian, K Gary
    Peterson, Tracy S
      Galey, Francis D

        MeSH Terms

        • Animal Feed / toxicity
        • Animals
        • Anti-Bacterial Agents / toxicity
        • Diagnosis, Differential
        • Fatal Outcome
        • Female
        • Food Contamination / analysis
        • Horse Diseases / chemically induced
        • Horse Diseases / diagnosis
        • Horse Diseases / pathology
        • Horses
        • Pyrans / toxicity

        Citations

        This article has been cited 16 times.
        1. Harte T, Smith D, Moore J, Wells B. Review of published research on primary dysautonomia of domestic animals. Vet Rec 2026 Jan 3;198(1):e30-e40.
          doi: 10.1002/vetr.5499pubmed: 40482055google scholar: lookup
        2. Hunt S, Thyagarajan A, Sahu RP. Dichloroacetate and Salinomycin as Therapeutic Agents in Cancer. Med Sci (Basel) 2025 Apr 23;13(2).
          doi: 10.3390/medsci13020047pubmed: 40407542google scholar: lookup
        3. Fong PM, Tang VY, Xu L, Yam BH, Pradeep HP, Feng Y, Tao L, Kao RY, Yang D. Synthetic Cation Transporters Eradicate Drug-Resistant Staphylococcus aureus, Persisters, and Biofilms. JACS Au 2025 Mar 24;5(3):1328-1339.
          doi: 10.1021/jacsau.4c01198pubmed: 40151269google scholar: lookup
        4. Henn D, Lensink AV, Botha CJ. Ultrastructural changes in cardiac and skeletal myoblasts following in vitro exposure to monensin, salinomycin, and lasalocid. PLoS One 2024;19(9):e0311046.
          doi: 10.1371/journal.pone.0311046pubmed: 39321180google scholar: lookup
        5. Woo WS, Shim SH, Kang G, Kim KH, Son HJ, Sohn MY, Lee S, Kim J, Seo JS, Kwon MG, Kim DH, Park CI. Assessment of Salinomycin's Potential to Treat Microcotyle sebastis in Korean Rockfish (Sebastes schlegelii). Animals (Basel) 2023 Oct 17;13(20).
          doi: 10.3390/ani13203233pubmed: 37893959google scholar: lookup
        6. Qin H, Guo Y. Targeting Telomerase Enhances Cytotoxicity of Salinomycin in Cancer Cells. ACS Omega 2022 Aug 30;7(34):30565-30570.
          doi: 10.1021/acsomega.2c04082pubmed: 36061682google scholar: lookup
        7. Henn D, Venter A, Ferreira GCH, Botha CJ. The In Vitro Cytotoxic Effects of Ionophore Exposure on Selected Cytoskeletal Proteins of C2C12 Myoblasts. Toxins (Basel) 2022 Jun 30;14(7).
          doi: 10.3390/toxins14070447pubmed: 35878184google scholar: lookup
        8. Ashrafihelan J, Eisapour H, Erfani AM, Kalantary AA, Amoli JS, Mozafari M. High mortality due to accidental salinomycin intoxication in sheep. Interdiscip Toxicol 2014 Sep;7(3):173-6.
          doi: 10.2478/intox-2014-0024pubmed: 26109896google scholar: lookup
        9. D'Alessandro S, Corbett Y, Ilboudo DP, Misiano P, Dahiya N, Abay SM, Habluetzel A, Grande R, Gismondo MR, Dechering KJ, Koolen KM, Sauerwein RW, Taramelli D, Basilico N, Parapini S. Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity. Antimicrob Agents Chemother 2015 Sep;59(9):5135-44.
          doi: 10.1128/AAC.04332-14pubmed: 26055362google scholar: lookup
        10. Wang Q, Wu P, Ren W, Xin K, Yang Y, Xie C, Yang C, Liu Q, Yu L, Jiang X, Liu B, Li R, Wang L. Comparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method. Nanoscale Res Lett 2014;9(1):351.
          doi: 10.1186/1556-276X-9-351pubmed: 25147486google scholar: lookup
        11. Boehmerle W, Muenzfeld H, Springer A, Huehnchen P, Endres M. Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice. J Mol Med (Berl) 2014 Aug;92(8):889-900.
          doi: 10.1007/s00109-014-1155-0pubmed: 24770997google scholar: lookup
        12. Zhou S, Wang F, Wong ET, Fonkem E, Hsieh TC, Wu JM, Wu E. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Curr Med Chem 2013;20(33):4095-101.
          doi: 10.2174/15672050113109990199pubmed: 23931281google scholar: lookup
        13. Ojo OO, Bhadauria S, Rath SK. Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice. PLoS One 2013;8(7):e69086.
          doi: 10.1371/journal.pone.0069086pubmed: 23840907google scholar: lookup
        14. Naujokat C, Steinhart R. Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol 2012;2012:950658.
          doi: 10.1155/2012/950658pubmed: 23251084google scholar: lookup
        15. Omidi A, Aslani MR, Movassaghi AR, Mohri M, Dadfar M. Accidental salinomycin intoxication in calves. Can Vet J 2010 Oct;51(10):1143-5.
          pubmed: 21197208
        16. Pakozdy A, Challande-Kathman I, Doherr M, Cizinauskas S, Wheeler SJ, Oevermann A, Jaggy A. Retrospective study of salinomycin toxicosis in 66 cats. Vet Med Int 2010;2010:147142.
          doi: 10.4061/2010/147142pubmed: 20445777google scholar: lookup